NCT04787250: A trial that was reported late by Adaptive Phage Therapeutics, Inc.
This trial was previously reported as an Applicable Clinical Trial, but is no longer.
Full data
| Full entry on ClinicalTrials.gov | NCT04787250 |
|---|---|
| Title | Randomized Open Label, Parallel Group, Controlled Study to Evaluate the Safety and Surgery Sparing Effect of Phage Therapy With Antibiotics for Patients With Prosthetic Joint Infections Who Are Candidates for Two Stage Exchange Arthroplasty |
| Results Status | no-longer-act |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Oct. 31, 2022 |
| Completion date | May 31, 2023 |
| Required reporting date | May 30, 2024, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | April 5, 2022 |
| Days late | None |